In silico drug design : repurposing techniques and methodologies /: repurposing techniques and methodologies. ([2019])
- Record Type:
- Book
- Title:
- In silico drug design : repurposing techniques and methodologies /: repurposing techniques and methodologies. ([2019])
- Main Title:
- In silico drug design : repurposing techniques and methodologies
- Further Information:
- Note: Edited by Kunal Roy.
- Editors:
- Roy, Kunal, 1971-
- Contents:
- Section 1. Introduction 1. Drug Repositioning: New Opportunities for Older Drugs 2. Computational Drug Design Methods – Current and Future Perspectives Section 2. Theoretical Background and Methodologies 3. In Silico Drug Design Methods for Drug Repurposing 4. Computational Drug Repurposing for Neurodegenerative Diseases 5. Repurposed molecules: A New Hope in Tackling Neglected Infectious Diseases 6. Molecular Docking: A Structure-Based Approach for Drug Repurposing 7. Data Science Driven Drug Repurposing for Metabolic Disorders 8. Data-driven Systems Level Approaches for Drug Repurposing: Combating Drug Resistance in Priority Pathogens 9. In Silico Repurposing of Cell Cycle Modulators for Cancer Treatment 10. Proteochemometric Modeling for Drug Repositioning 11. Drug Repurposing from Transcriptome Data: Methods and Applications 12. Omics-driven Knowledge Based Discovery of Anthelmintic Targets and Drugs 13. Analysis of Chemical Spaces: Implications for Drug Repurposing Section 3. Examples and Case Studies 14. Drug Repurposing in Search of Anti-Infectives: Need of the Hour in the Multi-Drug Resistance Era! 15. Application of In Silico Drug Repurposing in Infectious Diseases 16. In Silico Modeling of FDA-approved Drugs for Discovery of Anti-candida Agents: A Drug Repurposing Approach 17. In silico Modeling of FDA-approved Drugs for Discovery of Anticancer Agents: A Drug Repurposing Approach 18. Tackling Lung Cancer Drug Resistance using Integrated Drug Repurposing StrategySection 1. Introduction 1. Drug Repositioning: New Opportunities for Older Drugs 2. Computational Drug Design Methods – Current and Future Perspectives Section 2. Theoretical Background and Methodologies 3. In Silico Drug Design Methods for Drug Repurposing 4. Computational Drug Repurposing for Neurodegenerative Diseases 5. Repurposed molecules: A New Hope in Tackling Neglected Infectious Diseases 6. Molecular Docking: A Structure-Based Approach for Drug Repurposing 7. Data Science Driven Drug Repurposing for Metabolic Disorders 8. Data-driven Systems Level Approaches for Drug Repurposing: Combating Drug Resistance in Priority Pathogens 9. In Silico Repurposing of Cell Cycle Modulators for Cancer Treatment 10. Proteochemometric Modeling for Drug Repositioning 11. Drug Repurposing from Transcriptome Data: Methods and Applications 12. Omics-driven Knowledge Based Discovery of Anthelmintic Targets and Drugs 13. Analysis of Chemical Spaces: Implications for Drug Repurposing Section 3. Examples and Case Studies 14. Drug Repurposing in Search of Anti-Infectives: Need of the Hour in the Multi-Drug Resistance Era! 15. Application of In Silico Drug Repurposing in Infectious Diseases 16. In Silico Modeling of FDA-approved Drugs for Discovery of Anti-candida Agents: A Drug Repurposing Approach 17. In silico Modeling of FDA-approved Drugs for Discovery of Anticancer Agents: A Drug Repurposing Approach 18. Tackling Lung Cancer Drug Resistance using Integrated Drug Repurposing Strategy 19. In Silico Modeling of FDA-approved Drugs for Discovery of Anti-cancer Agents: A Drug Repurposing Approach 20. Drug Repurposing by Connectivity Mapping and Structural Modeling 21. In Silico Modeling of FDA-approved Drugs for Discovery of Therapies Against Neglected Diseases: A Drug Repurposing Approach 22. Ascorbic Acid is a Potential Inhibitor of Collagenases – In Silico and In Vitro Biological Studies 23. Bioinformatic Approaches for Repurposing and Repositioning Antibiotics, Antiprotozoals and Antivirals Section 4. Tools and databases 24. In Silico Databases and Tools for Drug Repurposing 25. An Overview of Computational Methods, Tools, Servers and Databases for Drug Repurposing 26. In silico Drug Repurposing for MDR Bacteria: Opportunities and Challenges 27. Drug Repositioning Strategies to Explore New Candidates Treating Prostate Cancer 28. PDID: Database of Experimental and Putative Drug Targets in Human Proteome … (more)
- Publisher Details:
- London : Academic Press
- Publication Date:
- 2019
- Extent:
- 1 online resource
- Subjects:
- 615.1/9
Drugs -- Design -- Methodology
Drugs -- Design -- Data processing
Drug development -- Methodology
MEDICAL / Pharmacology
Electronic books - Languages:
- English
- ISBNs:
- 9780128163771
0128163771 - Related ISBNs:
- 9780128161258
0128161256 - Notes:
- Note: Includes bibliographical references and index.
Note: Online resource; title from PDF title page (EBSCO, viewed February 15, 2019). - Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.389265
- Ingest File:
- 02_382.xml